Le Lézard
Classified in: Health, Science and technology
Subject: PDT

Mobile World Congress & 4YFN 2024: AI-Powered Weight Loss Launches in The Netherlands


Four Dutch Clients Launch Commercial Weight Loss Programs Powered by Sinquetm

THE HAGUE, The Netherlands, Feb. 22, 2024 /PRNewswire-PRWeb/ -- EW2Health (Easy Way to Health), a technology company specializing in data-driven solutions for health professionals, is excited to announce the commercial launch of Sinque, its patented behavioral analytics and monitoring solution for weight loss, in the Netherlands. EW2Health will showcase Sinque at Mobile World Congress in 4YFN (Hall 8.0, Stand 8.0B20.5) February 26?29, and present on the Superconnectors Barcelona stage after winning one of six coveted pitch spots for startups. Watch this short video to learn more about Sinque.

"Sinque is an innovative tool that allows for even more personalized treatment to achieve optimal results. It complements the suite of tools we already use, supports remote monitoring of our patients, and enables us to expand our business beyond our physical locations."

"We are thrilled to commercially launch Sinque in the Netherlands and partner with health professionals to improve the success rates of their weight loss programs," said J'Amy Stewart, CEO and co-founder of EW2Health. "Our technology has been proven to revolutionize weight management programs, providing better results for businesses, professionals and patients. We are confident that Sinque will make a significant impact in the Netherlands and beyond."

Sinque has already gained traction in the Dutch market with four customers launching weight loss programs powered by its patented AI-driven predictive analytics solution. These clients include well-known and boutique GLP-1 medical weight loss clinics that prescribe drugs like Wegovy and Saxenda, and nutritionist clinics that have recognized the potential of Sinque: Healthy Weight Clinics, Kliniek de Pauw, Voedingsadviesbureau De Winter and Diëtistenpraktijk ToV.

Bert Stelder, MD, and Mia Hendriks, RN, are co-owners of Healthy Weight Clinics, a bustling GLP-1 medical weight loss clinic with multiple locations in the Netherlands, including Amsterdam. "We're excited to use Sinque with our patients seeking sustainable weight management solutions," Dr. Stelder said. "Sinque is an innovative tool that allows for even more personalized treatment to achieve optimal results. It complements the suite of tools we already use, supports remote monitoring of our patients, and enables us to expand our business beyond our physical locations."

How Sinque Works

Sinque's patented algorithm, invented by EW2Health's founder, Renato Romani, MD, uses predictive behavior analytics and AI to learn users' weight fluctuation patterns and predict their individual 'true' weight trend. Patients track their progress via the Sinque app and a numberless monitor, which eliminates frustrations with the ups-and-downs on the scale. Professionals, for the first time, can provide truly personalized healthcare in the form of proactive, tailored support based on data and individual needs. Combined, Sinque results in a more successful, sustainable weight-loss journey.

Mark Mesman, general manager of Voedingsadviesbureau De Winter, a 17-location dietitian practice operating in North and South Holland, added, "With Sinque, our clients let go of the numbers and focus on lifestyle change, increasing motivation and self-confidence during treatment, while we have data to better personalize their experience. We can easily see how all of our patients are doing and not be in the dark between appointments. We know when to celebrate successes with our clients, and, more importantly, we know when to offer extra support and guidance."

Benefits of Sinque

EW2Health's achievement in the Netherlands marks an exciting milestone for the company as it continues to grow and make a positive impact in the health industry. With Sinque's innovative technology, EW2Health is set to revolutionize weight loss programs across the globe and improve the overall health and well-being of individuals.

Interested media, industry partners and investors are invited to contact [email protected] to set up a meeting in Barcelona at MWC and 4YFN 2024, February 26?29, 2024. Access the press kit here.

About EW2Health

EW2Health BV is a pioneering Dutch technology startup with friendly, data-driven solutions that enable personalized health using AI-based predictive behavioral analytics. EW2Health's first goal is to reverse the global obesity epidemic and significantly reduce associated healthcare costs through effective personalized healthcare. Founded in 2018, EW2Health is a privately held company headquartered in The Hague. Follow EW2Health on LinkedIn or learn more at www.easywaytohealth.com.

Media Contact

J'Amy Stewart, EW2Health BV, 31 6-2513-1198, [email protected], www.easywaytohealth.com

SOURCE EW2Health BV


These press releases may also interest you

at 13:00
Mallinckrodt plc, a global specialty pharmacy company, today announced that submissions for its 2024 Extracorporeal Immunomodulation Award (EIA) will open on 13 April 2024 during the 50th Annual Meeting of...

13 avr 2024
Experts from NYU Langone's Department of Neurology present their latest clinical findings and research discoveries at the American Academy of Neurology (AAN) 2024 Annual Meeting, April 13 to 18, in Denver....

13 avr 2024
MyAdvisor, a holistic wellness technology company, has been awarded the 2023-2024 Platinum Level Bell Seal...

13 avr 2024
Biohaven's first-in-class Molecular Degrader of Extracellular Proteins (MoDEtm) technology targeting IgG removal, BHV-1300, was selected for an oral presentation at AAN highlighting its novel mechanism of action and the latest preclinical data...

13 avr 2024
On Apr. 11, 2024, VITAL HealthCare, one of the 5 core business divisions of the VITAL Group, marked a stunning debut at the 89th China International Medical Equipment Fair (CMEF) in Shanghai. Drawing on the Group's core competence in R&D and its...

12 avr 2024
The report titled "STD Testing Market by Type (Blood Tests, Lumbar Puncture, Swab Tests), Product Type (Instruments, Reagents & Kits), Test Settings, Indication, End-user - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...



News published on and distributed by: